Curing Cancer in the Elderly Through Novel Strategies
Claudia Gravekamp, Associate Professor, Albert Einstein College of Medicine
Claudia Gravekamp, PhD, is an Associate Professor in the Department of Microbiology and Immunology of the Albert Einstein College of Medicine in New York, and a member of the Albert Einstein Cancer Center. She received her PhD in 1988 in the field of Tumor Immunology at the Erasmus University in Rotterdam, The Netherlands. From 1987 to 1993, she served as head of the Laboratory for Leptospirosis at the Royal Tropical Institute in Amsterdam, The Netherlands. In 1993, she started as a Research Fellow in Medicine at the Channing Laboratory of the Brigham and Women’s Hospital, Harvard Medical School, and soon became an Instructor in Medicine until 1998. There, she developed vaccines against Group B Streptococcus and gained expertise in the design and development of gene-driven vaccines. From 1998 to 2006, she was an Associate Member in the Institute for Drug Development of the Cancer Therapy and Research Center and an Assistant Professor at the University of Texas Health Science Center, in San Antonio, where she began to develop a program aimed at genetic vaccines for breast cancer. From 2006-2008, she was a Scientist at the California Pacific Medical Center Research Institute in San Francisco, continuing to develop novel immunotherapeutic approaches to cancer using attenuated Listeria monocytogenes as a platform to deliver anti-cancer agents selectively to the tumor microenvironment at young and old age. She has been funded by grants from the NIH, other grant agencies and private industry since 1999, published 55 scientific articles, is a member of the Editorial Board of Mechanisms of Ageing and Development, and is ad-hoc reviewer for various scientific journals.